free glp-1 tracker app Favorite for users? Pep GLP-1 Shot, Medication, and

le Roux et al

The Bridge is a major shift in access for Medicare beneficiaries who would otherwise be priced out

This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)

Em lares de renda mais alta, a reduo foi ainda maior, chegando a 9%